Advertisement

Clinical Reviews in Allergy & Immunology

, Volume 38, Issue 2–3, pp 298–301 | Cite as

Diagnostic Challenges in Celiac Disease and the Role of the Tissue Transglutaminase–Neo-Epitope

  • Torsten Matthias
  • Sascha Pfeiffer
  • Carlo Selmi
  • M. Eric Gershwin
Article

Abstract

The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as anti-gliadin antibodies.

Keywords

Celiac disease Tissue transglutaminase Anti-gliadin antibodies 

References

  1. 1.
    Schuppan D, Hahn EG (2001) IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol 13:635–637CrossRefPubMedGoogle Scholar
  2. 2.
    Gleicher N, Barad DH (2007) Gender as risk factor for autoimmune diseases. J Autoimmun 28:1–6CrossRefPubMedGoogle Scholar
  3. 3.
    Greco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, Paparo F, Gasperi V, Limongelli MG, Cotichini R, D'Agate C, Tinto N, Sacchetti L, Tosi R, Stazi MA (2002) The first large population based twin study of coeliac disease. Gut 50:624–628CrossRefPubMedGoogle Scholar
  4. 4.
    Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, Paparo F, D'Alfonso S, Giordano M, Sferlazzas C, Magazzu G, Momigliano-Richiardi P, Greco L, Stazi MA (2006) Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55:803–808CrossRefPubMedGoogle Scholar
  5. 5.
    Binard A, Le Pottier L, Saraux A, Devauchelle-Pensec V, Pers JO, Youinou P (2008) Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus? J Autoimmun 30:63–67CrossRefPubMedGoogle Scholar
  6. 6.
    Deane S, Meyers FJ, Gershwin ME (2008) On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 30:180–196CrossRefPubMedGoogle Scholar
  7. 7.
    Schuppan D (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119:234–242CrossRefPubMedGoogle Scholar
  8. 8.
    Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297:2275–2279CrossRefPubMedGoogle Scholar
  9. 9.
    Skovbjerg H, Koch C, Anthonsen D, Sjostrom H (2004) Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim Biophys Acta 1690:220–230PubMedGoogle Scholar
  10. 10.
    Skovbjerg H, Noren O, Anthonsen D, Moller J, Sjostrom H (2002) Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. Scand J Gastroenterol 37:812–817PubMedGoogle Scholar
  11. 11.
    Fleckenstein B, Molberg O, Qiao SW, Schmid DG, von der Mulbe F, Elgstoen K, Jung G, Sollid LM (2002) Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 277:34109–34116CrossRefPubMedGoogle Scholar
  12. 12.
    Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM (2004) Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 279:17607–17616CrossRefPubMedGoogle Scholar
  13. 13.
    Ciccocioppo R, Di Sabatino A, Ara C, Biagi F, Perilli M, Amicosante G, Cifone MG, Corazza GR (2003) Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 134:516–524CrossRefPubMedGoogle Scholar
  14. 14.
    Mowat AM (2003) Coeliac disease—a meeting point for genetics, immunology, and protein chemistry. Lancet 361:1290–1292CrossRefPubMedGoogle Scholar
  15. 15.
    Dieterich W, Esslinger B, Schuppan D (2003) Pathomechanisms in celiac disease. Int Arch Allergy Immunol 132:98–108CrossRefPubMedGoogle Scholar
  16. 16.
    Dewar D, Pereira SP, Ciclitira PJ (2004) The pathogenesis of coeliac disease. Int J Biochem Cell Biol 36:17–24CrossRefPubMedGoogle Scholar
  17. 17.
    Hernandez L, Green PH (2006) Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 8:383–389CrossRefPubMedGoogle Scholar
  18. 18.
    Hansen D, Brock-Jacobsen B, Lund E, Bjorn C, Hansen LP, Nielsen C, Fenger C, Lillevang ST, Husby S (2006) Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care 29:2452–2456CrossRefPubMedGoogle Scholar
  19. 19.
    Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R (2005) Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 165:393–399CrossRefPubMedGoogle Scholar
  20. 20.
    Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, Flodman P, Zone JJ (2008) Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 31:160–165CrossRefPubMedGoogle Scholar
  21. 21.
    Green PH, Jabri B (2003) Coeliac disease. Lancet 362:383–391CrossRefPubMedGoogle Scholar
  22. 22.
    Rashtak S, Ettore MW, Homburger HA, Murray JA (2008) Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 28:805–813CrossRefPubMedGoogle Scholar
  23. 23.
    Stene LC, Witso E, Torjesen PA, Rasmussen T, Magnus P, Cinek O, Wetlesen T, Ronningen KS (2007) Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 29:44–51CrossRefPubMedGoogle Scholar
  24. 24.
    Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC, Gibson RA, Steele RH, Pollock WK (2006) Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 18:493–501CrossRefPubMedGoogle Scholar
  25. 25.
    Reeves GE (2004) Coeliac disease: against the grain. Intern Med J 34:521–525CrossRefPubMedGoogle Scholar
  26. 26.
    Baschal EE, Eisenbarth GS (2008) Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 31:1–6CrossRefPubMedGoogle Scholar
  27. 27.
    Harrison LC, Honeyman MC, Morahan G, Wentworth JM, Elkassaby S, Colman PG, Fourlanos S (2008) Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun 31:306–310CrossRefPubMedGoogle Scholar
  28. 28.
    Jacobson EM, Huber A, Tomer Y (2008) The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30:58–62CrossRefPubMedGoogle Scholar
  29. 29.
    McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN, Stewart GJ, Booth DR (2008) CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis. J Autoimmun 31:52–58CrossRefPubMedGoogle Scholar
  30. 30.
    Yang J, Danke N, Roti M, Huston L, Greenbaum C, Pihoker C, James E, Kwok WW (2008) CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J Autoimmun 31:30–41CrossRefPubMedGoogle Scholar
  31. 31.
    Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29:1–9CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  • Torsten Matthias
    • 1
  • Sascha Pfeiffer
    • 1
  • Carlo Selmi
    • 2
    • 3
  • M. Eric Gershwin
    • 3
  1. 1.AESKU.KIPP InstituteWendelsheimGermany
  2. 2.Department of Internal Medicine, IRCCS Istituto Clinico HumanitasUniversity of MilanMilanItaly
  3. 3.Division of Rheumatology, Allergy, and Clinical ImmunologyUniversity of CaliforniaDavisUSA

Personalised recommendations